FDA — authorised 5 May 1987
- Application: NDA019229
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: ZINC SULFATE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Zinc gluconate supplement on 5 May 1987
Yes. FDA authorised it on 5 May 1987; FDA authorised it on 18 July 2019; FDA authorised it on 3 May 2022.
ABRAXIS PHARM holds the US marketing authorisation.